Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin to reduce bleeding after coronary artery bypass grafting
IRCT201409304345N3Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Nov 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of desmopressin in coronary arteriosclerosis and postoperative hemorrhage, sponsored by Guilan University of Medical Sciences. Started Nov 2014; status: completed.
02
Drugs
desmopressin
03
Conditions
coronary arteriosclerosispostoperative hemorrhage
Beyond the preview
Go deeper on IRCT201409304345N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201409304345N3.